ORAI1 and cardiac hypertrophy: Therefore, this study examined changes in vagal discharge and investigated whether pyridostigmine can inhibit CaN/NFAT3/GATA4 and suppress Orai1/STIM1 complex formation as well as improve cardiac function in pressure overload‐induced cardiac hypertrophy.